• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Wall Street Beat

Glucotrack to effect a reverse stock split

June 13, 2025 By Sean Whooley

GlucoTrack updated Logo (1)

Glucotrack (Nasdaq:GCTK) announced that it plans to effect a 1-for-60 reverse stock split of its issued and outstanding common stock. Rutherford, New Jersey-based Glucotrack — maker of a long-term implantable continuous blood glucose monitor (CBGM) — intends for the split to go into effect when the market opens on Monday, June 16, 2025. Under the terms […]

Filed Under: Business/Financial News, Diabetes, Implants, Patient Monitoring, Technology, Wall Street Beat Tagged With: Glucotrack

Embecta eyes shift from insulin delivery to broader medical supplies focus

May 22, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications. The pure-play diabetes technology company has endured ups and downs since its 2022 spin-off from BD. That includes an FDA approval for a disposable insulin patch pump system in September 2024, only to be followed by the discontinuation […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: embecta

Medtronic to separate Diabetes business unit

May 21, 2025 By Sean Whooley

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company. The medtech giant said the strategic decision can create “a more focused Medtronic” with a more simplified portfolio in high-margin growth markets. At the same time, it creates an independent, scaled leader in diabetes. The new company — […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Initial Public Offering (IPO), MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Medtronic

Beta Bionics posts Q1 sales beat, raises 2025 guidance

May 6, 2025 By Sean Whooley

Beta Bionics Logo (1)

Beta Bionics (Nasdaq:BBNX) shares remained unmoved after hours today on first-quarter results that topped the consensus sales forecast. Following its first-quarter performance, Beta Bionics increased its full-year guidance. After previously projecting between $80 million and $85 million in revenue, it now expects between $82 million and $87 million. The Irvine, California-based automated insulin delivery technology developer […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Beta Bionics

Analysts are high on Dexcom after Q1 results, $750M repurchase program

May 1, 2025 By Sean Whooley

Dexcom updated Logo

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus forecast. Shares of DXCM ticked up 3% to $72.30 apiece in post-market trading on Thursday. However, before hours on Friday, shares fell 1.6% to $70.26 apiece. The San Diego-based continuous glucose monitor (CGM) maker reported profits of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Tandem stock rises after hours on Q1 sales beat

April 30, 2025 By Sean Whooley

Tandem Diabetes Care updated logo

Tandem Diabetes Care (Nasdaq:TNDM) shares got a boost after the market closed today on first-quarter results that beat the consensus forecast. Shares of TNDM ticked up 6.2% to $17.89 apiece in post-market trading today. The San Diego-based automated insulin delivery technology company reported losses of $130.56 million. That equals 1.97 per share on sales of […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Tandem Diabetes Care

Ypsomed to sell diabetes business, insulin delivery tech to TecMed for $517.7M

April 22, 2025 By Sean Whooley

Ypsomed TecMed

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million (CHF 420 million). Burgdorf, Switzerland–based Ypsomed says the sale helps it focus on strengthening its position in the subcutaneous self-injection market. TecMed — also based in Burgdorf — can now add Ypsomed’s insulin delivery technology […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Technology, Wall Street Beat Tagged With: TecMed, Ypsomed

Retractable Technologies cuts workforce as it reduces reliance on China amid trade war

April 11, 2025 By Sean Whooley

Retractable Technologies

Retractable Technologies (NYSE:RVP) announced today that it reduced its workforce by approximately 7%. The Little Elm, Texas-based maker of products like syringes and needles said the move comes as it allocates more resources to the U.S. It aims to increase U.S. manufacturing capabilities and reduce reliance on products produced in China. According to a news […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: Retractable Technologies

How ICU Medical plans to mitigate tariff impact

April 8, 2025 By Sean Whooley

This is the logo of ICU Medical.

Needham analysts report that ICU Medical (Nasdaq: ICUI) has a plan in place to handle its exposure to the tariffs imposed by the Trump Administration. Medtech stocks already took a hit last month as in response to Trump’s tariff policies. Trump’s rollout of new taxes on imports from nearly all countries last week triggered the latest market dip. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Legal News, Technology, Wall Street Beat Tagged With: ICU Medical

Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’

March 25, 2025 By Sean Whooley

Beta Bionics iLet bionic pancreas with Dexcom G7 and Abbott FreeStyle Libre 3 Plus

Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January. The Irvine, California-based automated insulin […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology, Wall Street Beat Tagged With: Beta Bionics

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 186
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS